Related Experiment Video
Updated: Jul 12, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Ventricular arrhythmia burden in ICD patients during the second wave of the COVID-19 pandemic
Benjamin Rath1, Florian Doldi2, Kevin Willy2
1Department of Cardiology II-Electrophysiology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany. benjamin.rath@ukmuenster.de.
Insights
During the second COVID-19 wave, implantable defibrillator (ICD) patients experienced a significant increase in ventricular arrhythmias (VA) requiring ICD therapies, contrasting earlier pandemic findings.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- COVID-19 is linked to cardiovascular issues like ventricular arrhythmias (VA) and cardiac arrests.
- Initial reports suggested a decrease in VA burden among implantable defibrillator (ICD) patients during the first COVID-19 wave.
- Uncertainty remained regarding VA trends in later pandemic stages.
Purpose of the Study:
- To investigate if the reduced VA burden observed during the first COVID-19 wave persisted into the second wave.
- To assess changes in VA occurrence requiring ICD interventions during the second COVID-19 wave compared to a control period.
Main Methods:
- Retrospective analysis of 1674 patients with ICDs.
- Comparison of VA requiring ICD interventions during the second COVID-19 wave versus a control period.
- Device interrogations performed in an outpatient clinic setting.
Main Results:
- A significantly higher number of adequate ICD therapies were observed during the second COVID-19 wave.
- 4.5% of patients received appropriate ICD interventions during the COVID-19 period, versus 1.8% in the control period (p=0.01).
- Thirty-six patients experienced sustained VA requiring ICD intervention during the pandemic, compared to sixteen in the control group.
Conclusions:
- Contrary to the first wave, the second COVID-19 wave saw a significant increase in VA among ICD patients.
- Potential contributing factors include increased infection rates, vaccination side effects, behavioral changes, or reduced healthcare utilization.
- These findings highlight evolving cardiovascular risks associated with the COVID-19 pandemic.
Aim:
COVID-19 has been associated with cardiovascular complications including ventricular arrhythmias (VA) and an increased number of out-of-hospital cardiac arrests. Nevertheless, several authors described a decrease of VA burden in patients with an implantable defibrillator (ICD) during the first wave of the COVID-19 pandemic. The objective of this study was to determine if these observations could be transferred to later periods of the pandemic as well.
Methods:
We retrospectively analyzed a total of 1674 patients with an ICD presenting in our outpatient clinic during the second wave of the COVID-19 pandemic and during a control period for the occurrence of VA requiring ICD interventions.
Results:
Seven hundred ninety-five patients with an ICD had a device interrogation in our ambulatory clinic during the second wave of the COVID-19 pandemic compared to eight hundred seventy-nine patients in the control period. There was significant higher amount of adequate ICD therapies in the course of the COVID-19 period. Thirty-six patients (4.5%) received in total eighty-five appropriate ICD interventions during COVID-19, whereas only sixteen patients (1.8%) had sustained VA in the control period (p = 0.01).
Conclusion:
In contrast to the first wave of COVID-19, which was characterized by a decrease or least stable number of ICD therapies in several centers, we found a significant increase of VA in ICD patients during the second wave of COVID-19. Possible explanations for this observation include higher infectious rates, potential cardiac side effects of the vaccination as well as personal behavioral changes, or reduced utilization of medical services.
More Related Videos
16:40A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Mechanism of Cardiac Arrhythmias
Cardiomyopathy V: Interprofessional Care